Ziresovir reduces signs, symptoms of bronchiolitis in babies with RSV
WEB2 days ago — by Elana Gotkine. For infants and young children hospitalized with respiratory syncytial virus (RSV) infection, ziresovir reduces signs and symptoms of bronchiolitis, according to a study ...
Ziresovir Reduces Bronchiolitis in Infants Hospitalized With RSV
WEB3 days ago — The trial's findings demonstrate that ziresovir significantly improved clinical outcomes in infants and young children hospitalized with RSV. In the intention-to-treat population of 244 ...
Ziresovir Eases Bronchiolitis, Is Safe For Children Two Years And ...
WEB4 days ago — Researchers found that “from baseline to day 3, the RSV F protein inhibitor ziresovir resulted in a 30% greater decrease in the Wang bronchiolitis clinical score compared with placebo.” Study results indicate that “the proportion of children with a reduction of at least 75% on the 0-12 scale at day 3 also favored the ziresovir group.”
Novel Antiviral Appears Effective for Severe RSV in Infants, Toddlers
WEB4 days ago — From baseline to day 3, the RSV F protein inhibitor ziresovir resulted in a 30% greater decrease in the Wang bronchiolitis clinical score compared with placebo (-3.4 vs -2.7 points; difference...
Ziresovir Reduces Signs, Symptoms of Bronchiolitis in Babies With …
WEB3 days ago — The researchers observed a significantly greater reduction from baseline in the Wang bronchiolitis clinical score at day 3 with ziresovir than with placebo (−3.4 versus −2.7 points). At day 5, the reduction in the RSV viral load was greater in the ziresovir group than the placebo group (−2.5 versus −1.9 log 10 copies/mL). Prespecified ...
Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus ...
WEB5 days ago — Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the...
Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus ...
WEB4 days ago — Background: Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the treatment of infants hospitalized with RSV infection.
Ziresovir in Hospitalized Infants with RSV Infection
WEBZiresovir in Hospitalized Infants with RSV Infection. No respiratory syncytial virus vaccines are approved for children, and the only available treatment, aerosolized ribavirin, has …
'Encouraging': Antiviral ziresovir shows promise against RSV
WEB3 days ago — The investigational antiviral ziresovir showed promise for the treatment of respiratory syncytial virus infection in infants during a phase 3 trial in China, researchers reported in The New ...
WEB4 days ago — Ziresovir treatment reduced signs and symptoms of bronchiolitis in infants and young children hospitalized with RSV infection. No safety concerns were identified.